SK286413B6 - Tuhá farmaceutická kompozícia tvarovateľná za tepla s riadeným uvoľňovaním ivabradínu - Google Patents

Tuhá farmaceutická kompozícia tvarovateľná za tepla s riadeným uvoľňovaním ivabradínu Download PDF

Info

Publication number
SK286413B6
SK286413B6 SK942-2003A SK9422003A SK286413B6 SK 286413 B6 SK286413 B6 SK 286413B6 SK 9422003 A SK9422003 A SK 9422003A SK 286413 B6 SK286413 B6 SK 286413B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
ivabradine
controlled release
composition according
solid pharmaceutical
Prior art date
Application number
SK942-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK9422003A3 (en
Inventor
Patrick Wuthrich
Herv Rolland
Gilles Briault
G�Rard Pichon
Franois Tharrault
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of SK9422003A3 publication Critical patent/SK9422003A3/sk
Publication of SK286413B6 publication Critical patent/SK286413B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK942-2003A 2000-12-26 2001-12-21 Tuhá farmaceutická kompozícia tvarovateľná za tepla s riadeným uvoľňovaním ivabradínu SK286413B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017015A FR2818552B1 (fr) 2000-12-26 2000-12-26 Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
PCT/FR2001/004134 WO2002051387A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Publications (2)

Publication Number Publication Date
SK9422003A3 SK9422003A3 (en) 2003-12-02
SK286413B6 true SK286413B6 (sk) 2008-09-05

Family

ID=8858190

Family Applications (1)

Application Number Title Priority Date Filing Date
SK942-2003A SK286413B6 (sk) 2000-12-26 2001-12-21 Tuhá farmaceutická kompozícia tvarovateľná za tepla s riadeným uvoľňovaním ivabradínu

Country Status (27)

Country Link
US (1) US20040028743A1 (no)
EP (1) EP1345594B1 (no)
JP (2) JP2004518665A (no)
KR (1) KR100542472B1 (no)
CN (1) CN1203844C (no)
AT (1) ATE352290T1 (no)
AU (1) AU2002228119B2 (no)
BR (1) BR0116548A (no)
CA (1) CA2432645A1 (no)
CY (1) CY1106390T1 (no)
CZ (1) CZ304587B6 (no)
DE (1) DE60126332T2 (no)
DK (1) DK1345594T3 (no)
EA (1) EA005814B1 (no)
ES (1) ES2280420T3 (no)
FR (1) FR2818552B1 (no)
HK (1) HK1060514A1 (no)
HU (1) HU229410B1 (no)
MX (1) MXPA03005840A (no)
NO (1) NO333776B1 (no)
NZ (1) NZ526406A (no)
PL (1) PL203835B1 (no)
PT (1) PT1345594E (no)
SI (1) SI1345594T1 (no)
SK (1) SK286413B6 (no)
WO (1) WO2002051387A1 (no)
ZA (1) ZA200304441B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
GB2418854B (en) 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
FR2882553B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2010128525A2 (en) 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
US20130116239A1 (en) 2010-06-14 2013-05-09 ratiopharm GnbH Ivabradine-containing pharmaceutical composition with modified release
CN101897682B (zh) * 2010-07-13 2012-02-15 石药集团欧意药业有限公司 一种伊伐布雷定或其可药用盐固体制剂及其制备方法
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
EP3082772A1 (en) * 2013-12-20 2016-10-26 Synhton B.V. Pharmaceutical composition comprising amorphous ivabradine
EP3025705B8 (en) 2014-11-25 2018-11-28 Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi Stable ivabradine formulations
CN104398486B (zh) * 2014-12-08 2018-01-12 武汉武药科技有限公司 一种盐酸伊伐布雷定渗透泵控释片及其制备方法
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
CA2231050A1 (en) * 1995-09-07 1997-03-13 Biovail International Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
CN1159012C (zh) * 1997-08-26 2004-07-28 阿旺蒂斯制药公司 用于组合哌啶子基烷醇-减充血剂的药物组合物
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
DE19901040A1 (de) * 1999-01-14 2000-07-20 Knoll Ag Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Also Published As

Publication number Publication date
NO20032737L (no) 2003-06-16
BR0116548A (pt) 2003-12-23
US20040028743A1 (en) 2004-02-12
DK1345594T3 (da) 2007-05-21
ZA200304441B (en) 2004-06-25
JP2004518665A (ja) 2004-06-24
PL203835B1 (pl) 2009-11-30
EA005814B1 (ru) 2005-06-30
EA200300667A1 (ru) 2003-12-25
SI1345594T1 (sl) 2007-04-30
SK9422003A3 (en) 2003-12-02
EP1345594A1 (fr) 2003-09-24
PT1345594E (pt) 2007-04-30
WO2002051387A8 (fr) 2004-05-13
PL361662A1 (en) 2004-10-04
CN1482901A (zh) 2004-03-17
CY1106390T1 (el) 2011-10-12
FR2818552A1 (fr) 2002-06-28
DE60126332D1 (de) 2007-03-15
NZ526406A (en) 2005-08-26
NO333776B1 (no) 2013-09-16
KR20030064876A (ko) 2003-08-02
DE60126332T2 (de) 2007-08-30
KR100542472B1 (ko) 2006-01-11
HK1060514A1 (en) 2004-08-13
AU2002228119B2 (en) 2006-04-27
EP1345594B1 (fr) 2007-01-24
CZ304587B6 (cs) 2014-07-23
MXPA03005840A (es) 2003-09-10
HUP0302522A2 (hu) 2003-12-29
JP2010100641A (ja) 2010-05-06
CA2432645A1 (fr) 2002-07-04
FR2818552B1 (fr) 2003-02-07
CN1203844C (zh) 2005-06-01
HU229410B1 (en) 2013-12-30
CZ20032020A3 (cs) 2003-11-12
ATE352290T1 (de) 2007-02-15
WO2002051387A1 (fr) 2002-07-04
NO20032737D0 (no) 2003-06-16
ES2280420T3 (es) 2007-09-16
HUP0302522A3 (en) 2007-09-28

Similar Documents

Publication Publication Date Title
US6319520B1 (en) Solid thermoformable controlled-release pharmaceutical composition
JP2010100641A (ja) イバブラジン制御放出のための熱成形可能な固形医薬組成物
PL195543B1 (pl) Wielojednostkowe preparaty do podawania doustnego, o przedłużonym uwalnianiu dawek, z kontrolowanymuwalnianiem, niezależnym od pobudzania i sposób ich wytwarzania
SK286920B6 (sk) Tuhá farmaceutická kompozícia tvarovateľná za tepla s riadeným uvoľňovaním perindoprilu
FR2818549A1 (fr) Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
MXPA00006383A (en) Solid thermoformable controlled-release pharmaceutical composition

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20181221